A coordinated funding mechanism based on the broad engagement of the GloPID-R membership has been a longstanding priority of our funders’ coalition. The current initiative builds on past recommendations of the GloPID-R Scientific Advisory Group and the approval of the GloPID-R membership at the General Assembly in October 2023 in Berlin.
This initiative is designed to leverage the research investments already being made by members in pandemic preparedness and clinical trials, to add value and create something “greater than the sum of its parts”. While national level funders will contribute, the overarching aim is to achieve multinational collaboration.
The GRIPP group is exploring potential topics as well as the scope and processes of the first call, planned for late 2024. Two options are currently under consideration as the focus of the first call:
- Strengthening the clinical research ecosystem in low and middle-income countries
- Improving collaborative surveillance research and risk prediction
The structure of the future coordinated funding call will be overseen by a dedicated Stakeholder Group with input from researchers, policy makers and communities. The GloPID-R Secretariat will coordinate the development of this initiative, which builds on the principles set out in the GloPID-R Funders Living Roadmap for Clinical Trial Coordination.
The GloPID-R Coordinated Funding Mechanism is informed by a model developed by the Global Alliance for Chronic Diseases (GACD) Secretariat and receives support from DLR-PT in Germany, which will provide support through the use of its portal for the call mechanism.
